The first patient has been dosed in a clinical trial testing Sardocor's one-time gene therapy for cardiomyopathy associated ...

imageimageFOXK2 was identified as a novel pathogenic gene for congenital myopathy associated with ptosis and was shown to play a previously unreported, significant role in skeletal muscle development.